Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Benign Prostatic Hyperplasia Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.4% during the forecast period.
This report presents the market size and development trends by detailing the Benign Prostatic Hyperplasia Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Benign Prostatic Hyperplasia Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Benign Prostatic Hyperplasia Devices industry and will help you to build a panoramic view of the industrial development.
Benign Prostatic Hyperplasia Devices Market, By Type:
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Benign Prostatic Hyperplasia Devices Market, By Application:
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Some of the leading players are as follows:
ProArc Medical LTD
Boston Scientific corporation
Urologix
Lumenis
Neotrac
Medifocus
Olympus corporation
Lisa Laser
Urotech GMBH
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Benign Prostatic Hyperplasia Devices Market: Technology Type Analysis
-
4.1 Benign Prostatic Hyperplasia Devices Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Benign Prostatic Hyperplasia Devices Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Transurethral Resection of the Prostate (TURP)
4.3.2 Transurethral Microwave Therapy (TUMT)
4.3.3 Transurethral Needle Ablation of the Prostate (TUNA)
4.3.4 Laser Surgery
4.3.5 Prostatic Stenting
4.3.6 Others
5 Benign Prostatic Hyperplasia Devices Market: Product Analysis
-
5.1 Benign Prostatic Hyperplasia Devices Product Market Share Analysis, 2018 & 2026
-
5.2 Benign Prostatic Hyperplasia Devices Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Benign Prostatic Hyperplasia Devices Market: Application Analysis
-
6.1 Benign Prostatic Hyperplasia Devices Application Market Share Analysis, 2018 & 2026
-
6.2 Benign Prostatic Hyperplasia Devices Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospitals and Clinics
6.3.2 Ambulatory Surgical Centers(ASC)
6.3.3 Home
6.3.4 Others
7 Benign Prostatic Hyperplasia Devices Market: Regional Analysis
-
7.1 Benign Prostatic Hyperplasia Devices Regional Market Share Analysis, 2018 & 2026
-
7.2 Benign Prostatic Hyperplasia Devices Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 ProArc Medical LTD
9.1.1 ProArc Medical LTD Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Boston Scientific corporation
9.2.1 Boston Scientific corporation Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Urologix
9.3.1 Urologix Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Lumenis
9.4.1 Lumenis Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Neotrac
9.5.1 Neotrac Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Medifocus
9.6.1 Medifocus Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Olympus corporation
9.7.1 Olympus corporation Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Lisa Laser
9.8.1 Lisa Laser Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Urotech GMBH
9.9.1 Urotech GMBH Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 70 Figures and 165 Tables)
Figure Transurethral Resection of the Prostate (TURP) Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Transurethral Microwave Therapy (TUMT) Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Transurethral Needle Ablation of the Prostate (TUNA) Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Laser Surgery Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Prostatic Stenting Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Others Benign Prostatic Hyperplasia Devices market, 2015 - 2026 (USD Million)
Figure Hospitals and Clinics market, 2015 - 2026 (USD Million)
Figure Ambulatory Surgical Centers(ASC) market, 2015 - 2026 (USD Million)
Figure Home market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Benign Prostatic Hyperplasia Devices market, by country, 2015 - 2026 (USD Million)
-
Table North America Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table North America Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table North America Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Canada Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Canada Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Europe Benign Prostatic Hyperplasia Devices market, by country, 2015 - 2026 (USD Million)
-
Table Europe Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Europe Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Europe Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Germany Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Germany Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table France Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table France Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Italy Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Italy Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Spain Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Spain Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Benign Prostatic Hyperplasia Devices market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table China Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table China Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Japan Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Japan Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table India Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table India Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Benign Prostatic Hyperplasia Devices market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table MEA Benign Prostatic Hyperplasia Devices market, by country, 2015 - 2026 (USD Million)
-
Table MEA Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table MEA Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table MEA Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Benign Prostatic Hyperplasia Devices market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Benign Prostatic Hyperplasia Devices market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Benign Prostatic Hyperplasia Devices market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table ProArc Medical LTD Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boston Scientific corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Urologix Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lumenis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Neotrac Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medifocus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Olympus corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lisa Laser Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Urotech GMBH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
